Companies: 10,795·Total market cap: $144.5T

Xilio Therapeutics, Inc.

Xilio Therapeutics, Inc.

XLONASDAQHealthcare● Active

$7.68

$-0.02(-0.26%)

Market Cap$45948204

P/E Ratio—

52W High$12.74

52W Low$6.468

Avg Volume48K

Open$7.80

Beta-0.09

股票排行：Biotechnology·Healthcare·查看全部市值排行 →

Xilio Therapeutics, Inc.（XLO）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · XLO · 截至 Jun 9, 2026

关键指标

EPS (TTM)—Earnings history

PE Ratio (TTM)—PE Ratio deep dive

Revenue (TTM)—Full revenue history

Dividend Yield不分红Dividend history

Shares Outstanding—Shares outstanding history

Next EarningsTBAEarnings history

探索 Xilio Therapeutics, Inc. 数据

分析师预测—

股息不分红

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

Xilio Therapeutics, Inc.

$7.68-0.26%$45.9M #2

Aligos Therapeutics, Inc.

$4.96+1.02%$30.7M #3

Actinium Pharmaceuticals, Inc.

$1.06-1.85%$33.3M #4

$9.07-1.63%$36.7M #5

Kezar Life Sciences, Inc.

$7.29+0.00%$53.9M #6

LAVA Therapeutics N.V.

$1.74-3.87%$45.8M

关于 Xilio Therapeutics, Inc.

CEORene Russo

IPO DateOct 22, 2021

Employees64

CountryUS

Websitexiliotx.com

Xilio Therapeutics, Inc. is a clinical-stage biotechnology firm dedicated to crafting immunotherapies aimed at strengthening the immune systems of cancer patients. A key part of their pipeline is XTX1…

Biotechnology HealthcareNASDAQUS

关于股票概览与关键数据

Xilio Therapeutics, Inc.（XLO）是 Biotechnology 行业的 Healthcare 类公司，于 Oct 22, 2021 在 NASDAQ 上市。截至最近交易日，XLO 股价为 $7.68，市值约为 $45.9M。过去12个月累计回报 —，年初至今回报 —。

常见问题

截至最近一个交易日，Xilio Therapeutics, Inc.（XLO）股价为 $7.68，在 NASDAQ 上市，52周区间为 $6.47 – $12.74。

XLO 最新股价XLO quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 9, 2026本内容不构成投资建议